[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Human Fibrinogen Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

April 2024 | 198 pages | ID: G6600403DB9DEN
APO Research

US$ 4,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

According to APO Research, The global Human Fibrinogen market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Human Fibrinogen include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical and Octapharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Fibrinogen, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Human Fibrinogen, also provides the sales of main regions and countries. Of the upcoming market potential for Human Fibrinogen, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Fibrinogen sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Fibrinogen market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Fibrinogen sales, projected growth trends, production technology, application and end-user industry.

Human Fibrinogen segment by Company
  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • Jiangxi Boya Bio-Pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • GREEN CROSS
  • Shanghai XinXing Medical
  • Octapharma
Human Fibrinogen segment by Type
  • Human Fibrinogen Concentrate
  • Animal Fibrinogen Concentrate
Human Fibrinogen segment by Application
  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
Human Fibrinogen segment by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Study Objectives

1. To analyze and research the global Human Fibrinogen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Human Fibrinogen market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Fibrinogen significant trends, drivers, influence factors in global and regions.

6. To analyze Human Fibrinogen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Fibrinogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Fibrinogen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Fibrinogen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Fibrinogen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Fibrinogen industry.

Chapter 3: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Human Fibrinogen in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
  1.2.1 Global Human Fibrinogen Sales Value (2019-2030)
  1.2.2 Global Human Fibrinogen Sales Volume (2019-2030)
  1.2.3 Global Human Fibrinogen Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives

2 HUMAN FIBRINOGEN MARKET DYNAMICS

2.1 Human Fibrinogen Industry Trends
2.2 Human Fibrinogen Industry Drivers
2.3 Human Fibrinogen Industry Opportunities and Challenges
2.4 Human Fibrinogen Industry Restraints

3 HUMAN FIBRINOGEN MARKET BY COMPANY

3.1 Global Human Fibrinogen Company Revenue Ranking in 2023
3.2 Global Human Fibrinogen Revenue by Company (2019-2024)
3.3 Global Human Fibrinogen Sales Volume by Company (2019-2024)
3.4 Global Human Fibrinogen Average Price by Company (2019-2024)
3.5 Global Human Fibrinogen Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Human Fibrinogen Company Manufacturing Base & Headquarters
3.7 Global Human Fibrinogen Company, Product Type & Application
3.8 Global Human Fibrinogen Company Commercialization Time
3.9 Market Competitive Analysis
  3.9.1 Global Human Fibrinogen Market CR5 and HHI
  3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
  3.9.3 2023 Human Fibrinogen Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion

4 HUMAN FIBRINOGEN MARKET BY TYPE

4.1 Human Fibrinogen Type Introduction
  4.1.1 Human Fibrinogen Concentrate
  4.1.2 Animal Fibrinogen Concentrate
4.2 Global Human Fibrinogen Sales Volume by Type
  4.2.1 Global Human Fibrinogen Sales Volume by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Human Fibrinogen Sales Volume by Type (2019-2030)
  4.2.3 Global Human Fibrinogen Sales Volume Share by Type (2019-2030)
4.3 Global Human Fibrinogen Sales Value by Type
  4.3.1 Global Human Fibrinogen Sales Value by Type (2019 VS 2023 VS 2030)
  4.3.2 Global Human Fibrinogen Sales Value by Type (2019-2030)
  4.3.3 Global Human Fibrinogen Sales Value Share by Type (2019-2030)

5 HUMAN FIBRINOGEN MARKET BY APPLICATION

5.1 Human Fibrinogen Application Introduction
  5.1.1 Congenital Fibrinogen Deficiency
  5.1.2 Surgical Procedures
5.2 Global Human Fibrinogen Sales Volume by Application
  5.2.1 Global Human Fibrinogen Sales Volume by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Human Fibrinogen Sales Volume by Application (2019-2030)
  5.2.3 Global Human Fibrinogen Sales Volume Share by Application (2019-2030)
5.3 Global Human Fibrinogen Sales Value by Application
  5.3.1 Global Human Fibrinogen Sales Value by Application (2019 VS 2023 VS 2030)
  5.3.2 Global Human Fibrinogen Sales Value by Application (2019-2030)
  5.3.3 Global Human Fibrinogen Sales Value Share by Application (2019-2030)

6 HUMAN FIBRINOGEN MARKET BY REGION

6.1 Global Human Fibrinogen Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Fibrinogen Sales by Region (2019-2030)
  6.2.1 Global Human Fibrinogen Sales by Region: 2019-2024
  6.2.2 Global Human Fibrinogen Sales by Region (2025-2030)
6.3 Global Human Fibrinogen Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Human Fibrinogen Sales Value by Region (2019-2030)
  6.4.1 Global Human Fibrinogen Sales Value by Region: 2019-2024
  6.4.2 Global Human Fibrinogen Sales Value by Region (2025-2030)
6.5 Global Human Fibrinogen Market Price Analysis by Region (2019-2024)
6.6 North America
  6.6.1 North America Human Fibrinogen Sales Value (2019-2030)
  6.6.2 North America Human Fibrinogen Sales Value Share by Country, 2023 VS 2030
6.7 Europe
  6.7.1 Europe Human Fibrinogen Sales Value (2019-2030)
  6.7.2 Europe Human Fibrinogen Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
  6.8.1 Asia-Pacific Human Fibrinogen Sales Value (2019-2030)
  6.8.2 Asia-Pacific Human Fibrinogen Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
  6.9.1 Latin America Human Fibrinogen Sales Value (2019-2030)
  6.9.2 Latin America Human Fibrinogen Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
  6.10.1 Middle East & Africa Human Fibrinogen Sales Value (2019-2030)
  6.10.2 Middle East & Africa Human Fibrinogen Sales Value Share by Country, 2023 VS 2030

7 HUMAN FIBRINOGEN MARKET BY COUNTRY

7.1 Global Human Fibrinogen Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Human Fibrinogen Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Human Fibrinogen Sales by Country (2019-2030)
  7.3.1 Global Human Fibrinogen Sales by Country (2019-2024)
  7.3.2 Global Human Fibrinogen Sales by Country (2025-2030)
7.4 Global Human Fibrinogen Sales Value by Country (2019-2030)
  7.4.1 Global Human Fibrinogen Sales Value by Country (2019-2024)
  7.4.2 Global Human Fibrinogen Sales Value by Country (2025-2030)
7.5 USA
  7.5.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.5.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.5.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.6 Canada
  7.6.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.6.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.6.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.7 Germany
  7.7.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.7.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.7.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.8 France
  7.8.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.8.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.8.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
  7.9.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.9.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.9.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.10 Italy
  7.10.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.10.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.10.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
  7.11.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.11.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.11.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
  7.12.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.12.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.12.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.13 China
  7.13.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.13.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.13.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.14 Japan
  7.14.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.14.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.14.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
  7.15.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.15.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.15.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
  7.16.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.16.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.16.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.17 India
  7.17.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.17.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.17.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.18 Australia
  7.18.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.18.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.18.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
  7.19.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.19.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.19.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
  7.20.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.20.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.20.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
  7.21.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.21.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.21.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
  7.22.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.22.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.22.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030
7.23 UAE
  7.23.1 Global Human Fibrinogen Sales Value Growth Rate (2019-2030)
  7.23.2 Global Human Fibrinogen Sales Value Share by Type, 2023 VS 2030
  7.23.3 Global Human Fibrinogen Sales Value Share by Application, 2023 VS 2030

8 COMPANY PROFILES

8.1 CSL Behring
  8.1.1 CSL Behring Comapny Information
  8.1.2 CSL Behring Business Overview
  8.1.3 CSL Behring Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.1.4 CSL Behring Human Fibrinogen Product Portfolio
  8.1.5 CSL Behring Recent Developments
8.2 LFB Group
  8.2.1 LFB Group Comapny Information
  8.2.2 LFB Group Business Overview
  8.2.3 LFB Group Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.2.4 LFB Group Human Fibrinogen Product Portfolio
  8.2.5 LFB Group Recent Developments
8.3 Shanghai RAAS Blood Products
  8.3.1 Shanghai RAAS Blood Products Comapny Information
  8.3.2 Shanghai RAAS Blood Products Business Overview
  8.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Portfolio
  8.3.5 Shanghai RAAS Blood Products Recent Developments
8.4 Jiangxi Boya Bio-Pharmaceutical
  8.4.1 Jiangxi Boya Bio-Pharmaceutical Comapny Information
  8.4.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
  8.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Portfolio
  8.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
8.5 Hualan Biological Engineering
  8.5.1 Hualan Biological Engineering Comapny Information
  8.5.2 Hualan Biological Engineering Business Overview
  8.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.5.4 Hualan Biological Engineering Human Fibrinogen Product Portfolio
  8.5.5 Hualan Biological Engineering Recent Developments
8.6 Harbin Pacific Biopharmaceutical
  8.6.1 Harbin Pacific Biopharmaceutical Comapny Information
  8.6.2 Harbin Pacific Biopharmaceutical Business Overview
  8.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Portfolio
  8.6.5 Harbin Pacific Biopharmaceutical Recent Developments
8.7 GREEN CROSS
  8.7.1 GREEN CROSS Comapny Information
  8.7.2 GREEN CROSS Business Overview
  8.7.3 GREEN CROSS Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.7.4 GREEN CROSS Human Fibrinogen Product Portfolio
  8.7.5 GREEN CROSS Recent Developments
8.8 Shanghai XinXing Medical
  8.8.1 Shanghai XinXing Medical Comapny Information
  8.8.2 Shanghai XinXing Medical Business Overview
  8.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.8.4 Shanghai XinXing Medical Human Fibrinogen Product Portfolio
  8.8.5 Shanghai XinXing Medical Recent Developments
8.9 Octapharma
  8.9.1 Octapharma Comapny Information
  8.9.2 Octapharma Business Overview
  8.9.3 Octapharma Human Fibrinogen Sales, Value and Gross Margin (2019-2024)
  8.9.4 Octapharma Human Fibrinogen Product Portfolio
  8.9.5 Octapharma Recent Developments

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS

9.1 Human Fibrinogen Value Chain Analysis
  9.1.1 Human Fibrinogen Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 Manufacturing Cost Structure
  9.1.4 Human Fibrinogen Sales Mode & Process
9.2 Human Fibrinogen Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 Human Fibrinogen Distributors
  9.2.3 Human Fibrinogen Customers

10 CONCLUDING INSIGHTS

11 APPENDIX

11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
  11.5.1 Secondary Sources
  11.5.2 Primary Sources

LIST OF TABLES

Table 1. Human Fibrinogen Industry Trends
Table 2. Human Fibrinogen Industry Drivers
Table 3. Human Fibrinogen Industry Opportunities and Challenges
Table 4. Human Fibrinogen Industry Restraints
Table 5. Global Human Fibrinogen Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Human Fibrinogen Revenue Share by Company (2019-2024)
Table 7. Global Human Fibrinogen Sales Volume by Company (Kg) & (2019-2024)
Table 8. Global Human Fibrinogen Sales Volume Share by Company (2019-2024)
Table 9. Global Human Fibrinogen Average Price (USD/Kg) of Company (2019-2024)
Table 10. Global Human Fibrinogen Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Human Fibrinogen Key Company Manufacturing Base & Headquarters
Table 12. Global Human Fibrinogen Company, Product Type & Application
Table 13. Global Human Fibrinogen Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Human Fibrinogen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Human Fibrinogen Concentrate
Table 18. Major Companies of Animal Fibrinogen Concentrate
Table 19. Global Human Fibrinogen Sales Volume by Type 2019 VS 2023 VS 2030 (Kg)
Table 20. Global Human Fibrinogen Sales Volume by Type (2019-2024) & (Kg)
Table 21. Global Human Fibrinogen Sales Volume by Type (2025-2030) & (Kg)
Table 22. Global Human Fibrinogen Sales Volume Share by Type (2019-2024)
Table 23. Global Human Fibrinogen Sales Volume Share by Type (2025-2030)
Table 24. Global Human Fibrinogen Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Human Fibrinogen Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Human Fibrinogen Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Human Fibrinogen Sales Value Share by Type (2019-2024)
Table 28. Global Human Fibrinogen Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Congenital Fibrinogen Deficiency
Table 30. Major Companies of Surgical Procedures
Table 31. Global Human Fibrinogen Sales Volume by Application 2019 VS 2023 VS 2030 (Kg)
Table 32. Global Human Fibrinogen Sales Volume by Application (2019-2024) & (Kg)
Table 33. Global Human Fibrinogen Sales Volume by Application (2025-2030) & (Kg)
Table 34. Global Human Fibrinogen Sales Volume Share by Application (2019-2024)
Table 35. Global Human Fibrinogen Sales Volume Share by Application (2025-2030)
Table 36. Global Human Fibrinogen Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Human Fibrinogen Sales Value by Application (2019-2024) & (US$ Million)
Table 38. Global Human Fibrinogen Sales Value by Application (2025-2030) & (US$ Million)
Table 39. Global Human Fibrinogen Sales Value Share by Application (2019-2024)
Table 40. Global Human Fibrinogen Sales Value Share by Application (2025-2030)
Table 41. Global Human Fibrinogen Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Table 42. Global Human Fibrinogen Sales by Region (2019-2024) & (Kg)
Table 43. Global Human Fibrinogen Sales Market Share by Region (2019-2024)
Table 44. Global Human Fibrinogen Sales by Region (2025-2030) & (Kg)
Table 45. Global Human Fibrinogen Sales Market Share by Region (2025-2030)
Table 46. Global Human Fibrinogen Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Human Fibrinogen Sales Value by Region (2019-2024) & (US$ Million)
Table 48. Global Human Fibrinogen Sales Value Share by Region (2019-2024)
Table 49. Global Human Fibrinogen Sales Value by Region (2025-2030) & (US$ Million)
Table 50. Global Human Fibrinogen Sales Value Share by Region (2025-2030)
Table 51. Global Human Fibrinogen Market Average Price (USD/Kg) by Region (2019-2024)
Table 52. Global Human Fibrinogen Market Average Price (USD/Kg) by Region (2025-2030)
Table 53. Global Human Fibrinogen Sales by Country: 2019 VS 2023 VS 2030 (Kg)
Table 54. Global Human Fibrinogen Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 55. Global Human Fibrinogen Sales by Country (2019-2024) & (Kg)
Table 56. Global Human Fibrinogen Sales Market Share by Country (2019-2024)
Table 57. Global Human Fibrinogen Sales by Country (2025-2030) & (Kg)
Table 58. Global Human Fibrinogen Sales Market Share by Country (2025-2030)
Table 59. Global Human Fibrinogen Sales Value by Country (2019-2024) & (US$ Million)
Table 60. Global Human Fibrinogen Sales Value Market Share by Country (2019-2024)
Table 61. Global Human Fibrinogen Sales Value by Country (2025-2030) & (US$ Million)
Table 62. Global Human Fibrinogen Sales Value Market Share by Country (2025-2030)
Table 63. CSL Behring Company Information
Table 64. CSL Behring Business Overview
Table 65. CSL Behring Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 66. CSL Behring Human Fibrinogen Product Portfolio
Table 67. CSL Behring Recent Development
Table 68. LFB Group Company Information
Table 69. LFB Group Business Overview
Table 70. LFB Group Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 71. LFB Group Human Fibrinogen Product Portfolio
Table 72. LFB Group Recent Development
Table 73. Shanghai RAAS Blood Products Company Information
Table 74. Shanghai RAAS Blood Products Business Overview
Table 75. Shanghai RAAS Blood Products Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 76. Shanghai RAAS Blood Products Human Fibrinogen Product Portfolio
Table 77. Shanghai RAAS Blood Products Recent Development
Table 78. Jiangxi Boya Bio-Pharmaceutical Company Information
Table 79. Jiangxi Boya Bio-Pharmaceutical Business Overview
Table 80. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 81. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Portfolio
Table 82. Jiangxi Boya Bio-Pharmaceutical Recent Development
Table 83. Hualan Biological Engineering Company Information
Table 84. Hualan Biological Engineering Business Overview
Table 85. Hualan Biological Engineering Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 86. Hualan Biological Engineering Human Fibrinogen Product Portfolio
Table 87. Hualan Biological Engineering Recent Development
Table 88. Harbin Pacific Biopharmaceutical Company Information
Table 89. Harbin Pacific Biopharmaceutical Business Overview
Table 90. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 91. Harbin Pacific Biopharmaceutical Human Fibrinogen Product Portfolio
Table 92. Harbin Pacific Biopharmaceutical Recent Development
Table 93. GREEN CROSS Company Information
Table 94. GREEN CROSS Business Overview
Table 95. GREEN CROSS Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 96. GREEN CROSS Human Fibrinogen Product Portfolio
Table 97. GREEN CROSS Recent Development
Table 98. Shanghai XinXing Medical Company Information
Table 99. Shanghai XinXing Medical Business Overview
Table 100. Shanghai XinXing Medical Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 101. Shanghai XinXing Medical Human Fibrinogen Product Portfolio
Table 102. Shanghai XinXing Medical Recent Development
Table 103. Octapharma Company Information
Table 104. Octapharma Business Overview
Table 105. Octapharma Human Fibrinogen Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 106. Octapharma Human Fibrinogen Product Portfolio
Table 107. Octapharma Recent Development
Table 108. Key Raw Materials
Table 109. Raw Materials Key Suppliers
Table 110. Human Fibrinogen Distributors List
Table 111. Human Fibrinogen Customers List
Table 112. Research Programs/Design for This Report
Table 113. Authors List of This Report
Table 114. Secondary Sources
Table 115. Primary Sources

LIST OF FIGURES

Figure 1. Human Fibrinogen Product Picture
Figure 2. Global Human Fibrinogen Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Fibrinogen Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Fibrinogen Sales (2019-2030) & (Kg)
Figure 5. Global Human Fibrinogen Sales Average Price (USD/Kg) & (2019-2030)
Figure 6. Global Human Fibrinogen Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Human Fibrinogen Concentrate Picture
Figure 10. Animal Fibrinogen Concentrate Picture
Figure 11. Global Human Fibrinogen Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 12. Global Human Fibrinogen Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Human Fibrinogen Sales Volume Share by Type (2019-2030)
Figure 14. Global Human Fibrinogen Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Human Fibrinogen Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Human Fibrinogen Sales Value Share by Type (2019-2030)
Figure 17. Congenital Fibrinogen Deficiency Picture
Figure 18. Surgical Procedures Picture
Figure 19. Global Human Fibrinogen Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 20. Global Human Fibrinogen Sales Volume Share 2019 VS 2023 VS 2030
Figure 21. Global Human Fibrinogen Sales Volume Share by Application (2019-2030)
Figure 22. Global Human Fibrinogen Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Human Fibrinogen Sales Value Share 2019 VS 2023 VS 2030
Figure 24. Global Human Fibrinogen Sales Value Share by Application (2019-2030)
Figure 25. Global Human Fibrinogen Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 26. Global Human Fibrinogen Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 27. Global Human Fibrinogen Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 28. Global Human Fibrinogen Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Human Fibrinogen Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Human Fibrinogen Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Europe Human Fibrinogen Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Human Fibrinogen Sales Value Share by Country (%), 2023 VS 2030
Figure 33. Asia-Pacific Human Fibrinogen Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Human Fibrinogen Sales Value Share by Country (%), 2023 VS 2030
Figure 35. Latin America Human Fibrinogen Sales Value (2019-2030) & (US$ Million)
Figure 36. Latin America Human Fibrinogen Sales Value Share by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Human Fibrinogen Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Human Fibrinogen Sales Value Share by Country (%), 2023 VS 2030
Figure 39. USA Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. USA Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. USA Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. Canada Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. Canada Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. Canada Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Germany Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Germany Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Germany Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. France Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. France Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. France Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. U.K. Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.K. Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. U.K. Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Italy Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Italy Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Italy Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Netherlands Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Netherlands Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Netherlands Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Nordic Countries Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Nordic Countries Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Nordic Countries Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. China Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. China Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. China Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. Japan Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. Japan Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. Japan Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. South Korea Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. South Korea Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. South Korea Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Southeast Asia Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Southeast Asia Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Southeast Asia Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. India Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. India Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. India Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Australia Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Australia Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Australia Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Mexico Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Mexico Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Mexico Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Brazil Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Brazil Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Brazil Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Turkey Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Turkey Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Turkey Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Saudi Arabia Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. Saudi Arabia Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. Saudi Arabia Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. UAE Human Fibrinogen Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 94. UAE Human Fibrinogen Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 95. UAE Human Fibrinogen Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 96. Human Fibrinogen Value Chain
Figure 97. Manufacturing Cost Structure
Figure 98. Human Fibrinogen Sales Mode & Process
Figure 99. Direct Comparison with Distribution Share
Figure 100. Distributors Profiles
Figure 101. Years Considered
Figure 102. Research Process
Figure 103. Key Executives Interviewed


More Publications